Unveiling therapeutic frontiers: DON/DRP-104 as innovative Plasma kallikrein inhibitors against carcinoma-associated hereditary angioedema shocks - a comprehensive molecular dynamics exploration.

MLA

Oduro-Kwateng, Ernest, and Mahmoud E. S. Soliman. “Unveiling Therapeutic Frontiers: DON/DRP-104 as Innovative Plasma Kallikrein Inhibitors against Carcinoma-Associated Hereditary Angioedema Shocks - a Comprehensive Molecular Dynamics Exploration.” Cell Biochemistry & Biophysics, vol. 82, no. 2, June 2024, pp. 1159–77. EBSCOhost, https://doi.org/10.1007/s12013-024-01266-0.

APA

Oduro-Kwateng, E., & Soliman, M. E. S. (2024). Unveiling therapeutic frontiers: DON/DRP-104 as innovative Plasma kallikrein inhibitors against carcinoma-associated hereditary angioedema shocks - a comprehensive molecular dynamics exploration. Cell Biochemistry & Biophysics, 82(2), 1159–1177. https://doi.org/10.1007/s12013-024-01266-0

Chicago

Oduro-Kwateng, Ernest, and Mahmoud E. S. Soliman. 2024. “Unveiling Therapeutic Frontiers: DON/DRP-104 as Innovative Plasma Kallikrein Inhibitors against Carcinoma-Associated Hereditary Angioedema Shocks - a Comprehensive Molecular Dynamics Exploration.” Cell Biochemistry & Biophysics 82 (2): 1159–77. doi:10.1007/s12013-024-01266-0.